In a rare prosecution of medical professionals, two Colorado paramedics were convicted of criminally negligent homicide in the 2019 death of Elijah McClain, an unarmed Black man. The paramedics had injected McClain with ketamine while he was in police custody, and he died a few days later. (New York Times)
Georgia pediatrician Melvin Perry, MD, was arrested after allegedly attempting to attack a lab technician who was trying to draw his blood. (WSB-TV 2)
A hospital worker who was fired for refusing to get a flu shot won a $45,000 payout from his former employer, Children’s Healthcare of Atlanta. (Newsweek)
The family of a South Carolina man who died following a misplaced catheter won a $900,000 settlement from the Regional Medical Center in Orangeburg. (WIS 10)
An Illinois nurse has been accused of diluting a nursing home patient’s morphine. (CBS News Chicago)
A Florida intensive care nurse has been accused of stealing 17 bags of fentanyl from HCA Florida Brandon Hospital. (WSB-TV 2)
Florida nurse practitioner Elizabeth Hernandez has been sentenced to 20 years in prison for her role in a $192 million scheme involving genetic tests and durable medical equipment, according to the U.S. Department of Justice (DOJ).
Delaware-based health system ChristianaCare will pay just over $47 million to settle a whistleblower lawsuit filed by its former chief compliance officer. Ronald Sherman had accused the health system of giving away free clinical services to doctors employed by Neonatology Associates in exchange for referrals to the health system’s neonatal intensive care unit. (Becker’s Hospital Review)
Embattled Phillips Respironics paid $2.4 million to settle claims that it gave kickbacks to sleep laboratories, according to federal prosecutors.
Ultragenyx will pay $6 million to resolve charges that it violated the False Claims Act in its marketing program for its rare-disease drug, burosumab (Crysvita), according to the DOJ. The company reportedly paid a genetic testing lab to provide test results that included the name of the healthcare provider, allegedly using that to find potential burosumab patients and their doctors.
Bayer won its first Roundup lawsuit, ending a five-trial losing streak. (Reuters)